{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:15:03Z","timestamp":1791695703197,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejmech.2024.117003","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T06:17:25Z","timestamp":1730269045000},"page":"117003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Natural phenol carbamates: Selective BuChE\/FAAH dual inhibitors show neuroprotection in an Alzheimer's disease mouse model"],"prefix":"10.1016","volume":"281","author":[{"given":"Kuanrong","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6529-5383","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-6557","authenticated-orcid":false,"given":"Wenjian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117003_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.117003_bib2","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical AD and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ejmech.2024.117003_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bpa.12734","article-title":"A\u03b2 oligomers trigger and accelerate A\u03b2 seeding","volume":"30","author":"Katzmarski","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejmech.2024.117003_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u0392 and tau in alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2024.117003_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainresbull.2022.10.006","article-title":"The central role of tau in Alzheimer's disease: from neurofibrillary tangle maturation to the induction of cell death","volume":"190","author":"Thal","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2024.117003_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2024.117003_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/revneuro-2019-0089","article-title":"Amyloid-beta, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues","volume":"31","author":"Majdi","year":"2020","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2024.117003_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.117003_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Kosak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib10","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an alzheimer's disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acs.jmedchem.0c01775","article-title":"Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates alzheimer-like pathology in old APP\/PS1 mice","volume":"64","author":"Viayna","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/acs.jnatprod.9b00561","article-title":"Aromatic esters of the crinane amaryllidaceae alkaloid ambelline as selective inhibitors of butyrylcholinesterase","volume":"83","author":"Marikova","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.117003_bib13","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1021\/acs.jmedchem.0c01129","article-title":"Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112273","article-title":"The structure-based optimization of delta-sultone-fused pyrazoles as selective BuChE inhibitors","volume":"201","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib15","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib16","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer's disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1039\/D2MD00087C","article-title":"Novel benzimidazole-based pseudoirreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model","volume":"13","author":"Spatz","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib18","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.117003_bib19","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41401-020-0385-7","article-title":"Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH\/MAGL inhibitors","volume":"41","author":"Ren","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.117003_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ijnp\/pyy033","article-title":"Inhibition of fatty acid amide hydrolase by PF-3845 alleviates the nitrergic and proinflammatory response in rat Hippocampus following acute stress","volume":"21","author":"Chen","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2024.117003_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/biom11040502","article-title":"Anti-inflammatory effects of fatty acid amide hydrolase inhibition in monocytes\/macrophages from alzheimer's disease patients","volume":"11","author":"Chiurchi\u00f9","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.117003_bib22","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.3390\/ijms22147711","article-title":"Fatty acid amide hydrolase (FAAH) inhibition modulates amyloid-beta-induced microglia polarization","volume":"22","author":"Grieco","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117003_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-021-02276-y","article-title":"Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease","volume":"18","author":"Ruiz-P\u00e9rez","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2024.117003_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cbf.3680","article-title":"The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease","volume":"40","author":"Jain","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejmech.2024.117003_bib25","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational design of multitarget-directed ligands: strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib26","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/med.21699","article-title":"From combinations to multitarget-directed ligands: a continuum in Alzheimer's disease polypharmacology","volume":"41","author":"Albertini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.117003_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138945012799499794","article-title":"Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment","volume":"13","author":"Weinreb","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2024.117003_bib28","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1021\/bi020016x","article-title":"Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine","volume":"41","author":"Bar-On","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.117003_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2017.10.007","article-title":"In vitro and in vivo pharmacological characterization of ASP8477: a novel highly selective fatty acid amide hydrolase inhibitor","volume":"815","author":"Watabiki","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117003_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejmech.2024.117003_bib31","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.jmedchem.7b01760","article-title":"Structure-activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles","volume":"61","author":"Dolles","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib32","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1021\/acs.jmedchem.9b00623","article-title":"Dual-acting cholinesterase-human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo","volume":"62","author":"Scheiner","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000036","article-title":"Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs","volume":"353","author":"Tripathi","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.117003_bib34","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acs.jmedchem.6b00609","article-title":"Fatty acid amide hydrolase (FAAH), acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-alzheimer's disease agents","volume":"59","author":"Montanari","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104684","article-title":"Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: molecular dynamic, in vitro and in vivo studies","volume":"109","author":"Maleki","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib36","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/molecules26113254","article-title":"New coumarin derivatives as cholinergic and cannabinoid system modulators","volume":"26","author":"Montanari","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117003_bib37","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/acs.jmedchem.3c00541","article-title":"Dual-acting small molecules: subtype-selective cannabinoid receptor 2 agonist\/butyrylcholinesterase inhibitor hybrids show neuroprotection in an alzheimer's disease mouse model","volume":"66","author":"Spatz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/molecules27030958","article-title":"A new series of aryloxyacetic acids endowed with multi-target activity towards peroxisome proliferator-activated receptors (PPARs), fatty acid amide hydrolase (FAAH), and acetylcholinesterase (AChE)","volume":"27","author":"Leuci","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117003_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105268","article-title":"Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells","volume":"78","author":"Herriage","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2024.117003_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2007.06.057","article-title":"Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury","volume":"264","author":"Wu","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2024.117003_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.intimp.2019.04.033","article-title":"Paeonol: pharmacological effects and mechanisms of action","volume":"72","author":"Zhang","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.117003_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117544","article-title":"Chemistry, pharmacokinetics, pharmacology and recent novel drug delivery systems of paeonol","volume":"250","author":"Adki","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.117003_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154930","article-title":"Eugenol relieves the pathological manifestations of Alzheimer's disease in 5\u00d7FAD mice","volume":"118","author":"Jung","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.117003_bib44","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1111\/ejn.15565","article-title":"Therapeutic effects of carvacrol on beta-amyloid-induced impairments in in vitro and in vivo models of Alzheimer's disease","volume":"56","author":"Celik Topkara","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.117003_bib45","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ddr.22113","article-title":"Carbamate as a potential anti-Alzheimer's pharmacophore: a review","volume":"84","author":"Singh","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2024.117003_bib46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1039\/D1MD00374G","article-title":"Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation","volume":"13","author":"Cristancho Ortiz","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300410","article-title":"Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents","volume":"356","author":"Papa","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.117003_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117926","article-title":"Current pharmacophore based approaches for the development of new anti-Alzheimer's agents","volume":"113","author":"Sharma","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib49","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/acs.jmedchem.3c00541","article-title":"Dual-acting small molecules: subtype-selective cannabinoid receptor 2 agonist\/butyrylcholinesterase inhibitor hybrids show neuroprotection in an alzheimer's disease mouse model","volume":"66","author":"Spatz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease","volume":"39","author":"Yu","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116071","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"265","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2024.117003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116794","article-title":"Design, synthesis, and biological evaluation of imidazolylacetophenone oxime derivatives as novel brain-penetrant agents for Alzheimer's disease treatment","volume":"278","author":"Bian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42255-023-00756-4","article-title":"Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration","volume":"5","author":"Mi","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2024.117003_bib55","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1080\/14756366.2018.1488696","article-title":"Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors","volume":"33","author":"Qiu","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113735","article-title":"Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease","volume":"223","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41386-020-00888-1","article-title":"The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study","volume":"46","author":"Schmidt","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2024.117003_bib58","article-title":"Fatty acid amide hydrolase levels in brain linked with threat-related amygdala activation","volume":"2","author":"Green","year":"2022","journal-title":"Neuroimage Rep"},{"key":"10.1016\/j.ejmech.2024.117003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111598","article-title":"Discovery of \u03b4-sultone-fused pyrazoles for treating Alzheimer's disease: design, synthesis, biological evaluation and SAR studies","volume":"181","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib60","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1002\/chem.202005263","article-title":"Azobioisosteres of curcumin with pronounced activity against amyloid aggregation, intracellular oxidative stress, and neuroinflammation","volume":"27","author":"Hofmann","year":"2021","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.117003_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202200786","article-title":"Synthesis and biological evaluation of flavonoid-cinnamic acid amide hybrids with distinct activity against neurodegeneration in vitro and in vivo","volume":"28","author":"Hofmann","year":"2022","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.117003_bib62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2024.117003_bib63","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.117003_bib64","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.21580","article-title":"Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB","volume":"98","author":"Di","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2024.117003_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroimage.2018.05.041","article-title":"Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia","volume":"178","author":"Evans","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejmech.2024.117003_bib66","article-title":"Specific hippocampal interneurons shape consolidation of recognition memory","volume":"32","author":"da Cruz","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.117003_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115502","article-title":"Sulfur-fluoride exchange (SuFEx)-enabled lead discovery of AChE inhibitors by fragment linking strategies","volume":"257","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117003_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.134036","article-title":"Low-dose bisphenol A exposure impairs learning and memory ability with alterations of neuromorphology and neurotransmitters in rats","volume":"697","author":"Zhang","year":"2019","journal-title":"Sci. Total Environ."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T08:56:26Z","timestamp":1734252986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":68,"alternative-id":["S0223523424008857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117003","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural phenol carbamates: Selective BuChE\/FAAH dual inhibitors show neuroprotection in an Alzheimer's disease mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117003"}}